These data were recently confirmed by analyzing an extensive database of hematological malignancies showing higher expression of P2X7 in CLL than in healthy bone marrow controls (Feng et al., 2020; Figure 1). Here, P2RX7 is linked to B-cell chronic lymphocytic leukemia.